Study to Evaluate Safety, Tolerability and Pharmacokinetics of G01 Eye Drops in Healthy Volunteers
Clinical trial NCT07779902 · COMPLETED
Trial details
- NCT number
- NCT07779902
- Sponsor
- Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2025-06-28
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.